Clinical trials recruiting for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ALN-PNP | 2 |
| Incretin-Based Therapy | 1 |
| Miricorilant | 1 |
| Niacin (250mg) | 1 |
| Tirzepatide | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 3 |
| California | 2 |
| Louisiana | 2 |
| Arizona | 1 |
| Florida | 1 |
| Indiana | 1 |
| Minnesota | 1 |
| Ohio | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Evaluating the Pharmacokinetics and Safety of Miricorilant
- Fibrosis Lessens After Metabolic Surgery
- Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
Related conditions
Trials recruiting for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.